Breast Cancer study: SOC
Official title Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
ClinicalTrials.gov ID: NCT05483283
What this study is testing
- What it's testing
- The study wants to see if the phone support helps these women get the care they need.
- Who it's for
- Latina women who have breast cancer and are at high genetic or social risk.
- What's involved
- Participants will have three 30‑minute phone calls with the study team over three weeks.
- Time commitment
- The study lasts three weeks, with one phone call each week.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 and older, women only
You may be able to join if
- Aim 1
- female biological sex
- identification as Latina
- one genetic risk factor (i.e., personal history of breast cancer or family history of breast or ovarian cancer)
- one SDH risk factor, based on the American Cancer Society's definitions (e.g., perceived financial struggles; transportation difficulties
You likely can't join if
- Aim 1 and Aim 2 Not meeting at least one of the inclusion criteria Aim 3
- Not a participant from Aim 1 or
- Not a participant from Aim 2
See the full eligibility criteria
- Aim 1
- female biological sex
- identification as Latina
- one genetic risk factor (i.e., personal history of breast cancer or family history of breast or ovarian cancer)
- one SDH risk factor, based on the American Cancer Society's definitions (e.g., perceived financial struggles; transportation difficulties; exposure to violence; housing challenges; social isolation/challenges)
- 30+ years old, based on American Cancer Society (ACS) screening guidelines for high risk populations
- No receipt of cancer genetic counseling AND no receipt of genetic testing Aim 2
- female biological sex
- referral from Latina Aim 1 participants
- eligibility to obtain BC screenings, based on ACS guidelines (e.g., optional annual
- screenings at 40-44 years old, recommended annual screenings at 45-54 years old, every other year screening at 55 and older)
- self-report not attending Session #3 (as this will not be recorded by the staff) Aim 3
- participant from Aim 1 or
- participant from Aim 2
- Aim 1 and Aim 2 Not meeting at least one of the inclusion criteria Aim 3
- Not a participant from Aim 1 or
- Not a participant from Aim 2
The study team makes the final eligibility decision.
Where it is enrolling
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 30 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.